Table 2.

Clinical Trial Enrollment by Demographic, Disease, and Treatment Factors

	Any trial n = 580 (37%)			Therapeutic trials n = 213 (14%)			Nontherapeutic trials n = 520 (33%)
	n	%	p	n	%	p	N	%	p
Primary insurance			1.00			0.17			0.98
Private	356	37		133	14		321	33
Public	111	37		31	10		101	33
Military	41	38		16	15		34	31
Uninsured/Self Pay	72	37		33	17		64	33
Age at diagnosis			0.13			0.04			0.21
15–19	56	43		29	22		45	34
20–24	58	33		19	11		52	29
25–29	100	37		33	12		93	34
30–34	139	33		53	13		123	30
35–39	227	39		79	14		207	36
Sex			0.14			0.23			0.10
Female	354	38		133	14		320	35
Male	226	35		80	12		200	31
Race/Ethnicity			0.03			0.11			0.04
Non-Hispanic White	364	37		132	14		330	34
Non-Hispanic Black	133	43		51	16		116	37
Hispanic	39	28		11	8		33	24
Non-Hispanic Other	32	34		14	15		30	32
Marital status			0.84			0.49			0.74
Single	283	39		100	14		251	34
Married	249	38		102	15		223	34
Separated/Divorced	32	41		9	11		30	38
Cancer stage			<0.001			<0.001			<0.001
In situ	5	9		0	0		5	9
Local	219	31		68	10		205	29
Regional	187	44		76	18		165	39
Distant	157	46		66	20		133	39
Cancer site			<0.001			<0.001			<0.001
Breast	91	54		49	29		75	44
Gynecologic	106	48		38	17		103	47
Testicular	28	33		8	9		23	27
CNS	28	33		7	8		27	32
GI	56	43		9	7		53	41
Head/Neck/Lung	34	42		17	21		31	38
Hematologic	107	40		49	18		90	33
Sarcoma	26	31		10	12		19	22
Skin	41	16		8	3		37	15
Thyroid	34	27		8	7		34	27
Other	29	42		10	15		28	41